Skip NavigationSkip to Content

Loss of myeloid-specific lamin A/C drives lung metastasis through Gfi-1 and C/EBPe-mediated granulocytic differentiation

  1. Author:
    Ishii, Hiroki
    Park, Woo-Yong
    So, Jaeyoung
    Kuhn,Skyler
    Koparde,Vishal
    Pang, Yanli
    Greten, Tim F
    Hollander, M Christine
    Yang, Li [ORCID]
  2. Author Address

    Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., CCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, NIH, Frederick, Maryland., Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.,
    1. Year: 2020
    2. Date: Jan 07
    3. Epub Date: 2020 01 07
  1. Journal: Molecular carcinogenesis
  2. Type of Article: Article
  3. ISSN: 0899-1987
  1. Abstract:

    The immune-suppressive tumor microenvironment promotes metastatic spread and outgrowth. One of the major contributors is tumor-associated myeloid cells. However, the molecular mechanisms regulating their differentiation and function are not well understood. Here we report lamin A/C, a nuclear lamina protein associated with chromatin remodeling, was one of the critical regulators in cellular reprogramming of tumor-associated myeloid cells. Using myeloid-specific lamin A/C knockout mice and triple-negative breast cancer (TNBC) mouse models, we discovered that the loss of lamin A/C drives CD11b+ Ly6G+ granulocytic lineage differentiation, alters the production of inflammatory chemokines, decreases host antitumor immunity, and increases metastasis. The underlying mechanisms involve an increased H3K4me3 leading to the upregulation of transcription factors (TFs) Gfi-1 and C/EBPe. Decreased lamin A/C and increased Gfi-1 and C/EBPe were also found in the granulocytic subset in the peripheral blood of human cancer patients. Our data provide a mechanistic understanding of myeloid lineage differentiation and function in the immune-suppressive microenvironment in TNBC metastasis. © 2020 The Authors. Molecular Carcinogenesis Published by Wiley Periodicals, Inc.

    See More

External Sources

  1. DOI: 10.1002/mc.23147
  2. PMID: 31912614
  3. WOS: 000505965800001

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel